Acumed Acquires ExsoMed to Enhance Its Portfolio of Upper Extremity Solutions

July 6, 2022

Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery.

The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to complex injuries.

“Demand for minimally invasive surgical devices continues to grow and the ExsoMed products are great additions to our minimally invasive offerings,” said Milton Torres, VP of Hand and Upper Extremity at Acumed. “ExsoMed’s innovative products are a natural fit for Acumed’s extensive portfolio of industry-first hand and wrist solutions. These products are designed to provide surgeons with in situ customization options to achieve optimal patient fit and restoration of function.”

Acumed has the most complete selection of upper extremity fixation and specialty plates on the market* – now complemented by ExsoMed’s threaded nails, which offer minimally invasive solutions to treat fractures, fusions, and late-stage arthritic conditions.

ExsoMed products include:

INnate™ – ExsoMed’s revolutionary solution for treating metacarpal fractures. INnate™ is an intramedullary threaded nail designed to provide surgeons with a reliable solution for treating metacarpal fractures through a simple, minimally invasive approach.

InFrame™ – designed specifically for phalanx fractures, providing surgeons with a reliable solution through a simple, minimally invasive approach. The robust length offering of InFrame™ is intended to accurately fit the intramedullary canal and achieve bicortical bone purchase, creating stable fixation and precise reduction for all types of phalanx fractures.

ArrowPhix™ – ExsoMed’s innovative arrow-shaped screw for functional variable angle DIP fusions. The related ArcPhix™ is an angled screw for strong, functional angle DIP fusions. Research has shown that when a patient’s distal interphalangeal joint is fused in a functional position, finger dexterity and grip strength improve over that of a patient with a straight, strength fusion.1

“Patients, surgeons, and innovation have been the key drivers in all of ExsoMed’s business decisions,” said James Young Kim, Chief Marketing Officer for ExsoMed. “The culture, history, and ambitions of Acumed align so naturally for us at ExsoMed that this decision to join the growing Acumed family was never second-guessed. We are grateful for the opportunity to expand ExsoMed’s technologies utilizing Acumed’s vast resources and continuing to raise the standard of care in hand surgery.”

“We are thrilled by the addition of ExsoMed to the extensive Acumed portfolio of innovative upper extremity, lower extremity, CMF, tendon, ligament, and orthobiologics solutions to better serve our customers worldwide,” said Hjalmar Pompe van Meerdervoort, President of Acumed. “With Acumed’s experience and vast resources, we are excited to combine efforts with ExsoMed to accelerate the shift in the standard of care for hand fractures.”